Phathom Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q3 2024.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.64M, a 8.23% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.9M, a 54.8% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45M, a 86.6% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24.1M, a 43.5% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.8M, a 188% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $41.9M $5.64M -$505K -8.23% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $42.4M $6.1M -$1.15M -15.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $43.6M $5.63M -$1.42M -20.2% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-06-14
Q4 2023 $45M $24.6M +$17.9M +269% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
Q3 2023 $27.1M $6.14M +$324K +5.57% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $26.8M $7.25M +$1.37M +23.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $25.4M $7.05M +$1.27M +22% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-06-14
Q4 2022 $24.1M $6.66M +$2.32M +53.5% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
Q3 2022 $21.8M $5.82M +$1.4M +31.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $20.4M $5.89M +$1.65M +38.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $18.8M $5.78M +$1.96M +51.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $16.8M $4.34M +$1.96M +82.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $14.9M $4.42M +$2.35M +113% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-09
Q2 2021 $12.5M $4.24M +$3.41M +412% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $9.1M $3.82M +$3.26M +578% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $5.84M $2.38M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $2.07M +$2.03M +5495% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $828K +$799K +2755% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $563K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $37K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $29K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.